You are here

FDA Policy

Off-Label Drug Information

Regulation, Distribution, Evaluation, and Related Controversies
C. Lee Ventola, MS
PDF version: 
Although one of the FDA’s main goals is to protect consumers from unsafe products, the off-label use of prescription drugs is quite common. The history and debate regarding the distribution of off-label drug information and the FDA’s inability to limit non-approved uses of pharmaceuticals are reviewed.